Feedback from the author

Clone/Cat no (supplier): #9101 (New Englanot done Biolabs); Host: rabbity (poly); western blot: we are happy with it; immunoprecipitation: not done; IF: we are happy with it; IHC: not done [ncbi , more ], to detect Akt and phospho-Akt in ET-1-treated lung fibroblasts from open lung biopsy specimens from SSc patients [ncbi , more ], to detect the presence of phosphorylated MAPK in porcine aortic endothelial (PAE) cells [ncbi , more ], to detect ERK2 and phospho-ERK2 in human ejaculate spermatozoa [ncbi , more ], to study the proangiogenic activity of AFP in the fetomaternal unit and its possible role during pregnancy in the present study [ncbi , more ], to demonstrate that MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts [ncbi , more ], to study the effect of Pyk2 on epidermal growth factor and c-Src-induced Stat3 activation in HeLa cell [ncbi , more ], to detect phospho-p42 ERK in NR6 WT cells and NR6 c'973 cells [ncbi , more ], to detect phospho-p42 MAPK in rat cardiac myocytes infected with recombinant adenoviruses containing human wild type or mutant cDNA of RasGAP, Akt or ILK [ncbi , more ], to detect phospho-ERK2 in 3T3-L1 cells infected with a retrovirus carrying the gene for C/EBPalpha [ncbi , more ], to study tumor necrosis factor-alpha signaling pathways [ncbi , more ], to study the role of CRHR2 in the control fo myometrial contractility [ncbi , more ], to study the function of RNase L and c-Jun NH2-terminal kinase in the interferon antiviral response [ncbi , more ], to study the role of adiponectin in angiogenesis [ncbi , more ]and to examined the Ser/Thr phosphorylation status of ERK in control HUVECs and HeLa cells [ncbi , more ]. Cell Signaling Technology ERK2 antibody was applied in 2003 to study the inhibition of lysophosphatidic acid acyltransferase beta on proliferative and survival signals in normal cells and apoptosis of tumor cells [ncbi , more ], to detect phosphorylated ERK in A549 cells infected with RSV [ncbi , more ], to detect p42 MAPK and phopho-p42 MAPK in SK-LMS-1 cells and MDA-MB-231 cells with human TSP1 transfection [ncbi , more ], to study the Initiation of CD38 signaling in T Cells within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor [ncbi , more ], to study the protective role of SCP and SRP against hypoxia/rexygenation injury in rat neonatal cardiomyocytes [ncbi , more ], to detect P42 MAPK and phospho-P42 MAPK in fibroblasts containing wild type Cas, CasY253F, or Cas118423 [ncbi , more ], to detect ERK2 and phospho-ERK2 in baculovirus infected with different versions of human Itk [ncbi , more ], to investigate the activation of ERK1/2 in primary human melanocytes isolated from neonatal foreskins and in the human melanoma SK-MEL-24 and SK-MEL-28 cell lines [ncbi , more ], to detect ERK2 and phospho-ERK2 in mutant and normal lymphocytes from patients [ncbi , more ], to study the interaction of Bcr kinase and AF-6 and the effects of them on Ras signaling [ncbi , more ], to study the expression, function, and signaling pathways of PCDGF in human MM [ncbi , more ], to determine whether differences in the activation of p38 by phosphorylation (p38-P) might contribute to the sex-dimorphic immune response following T-H [ncbi , more ], to identify two substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5 [ncbi , more ], to study the GIPC interaction with beta1-adrenergic receptor and its regulation on beta1-adrenergic receptor-mediated ERK activation [ncbi , more ], to study the role of Rit in human neuroblastoma cells for MEK-independent neurite branching [ncbi , more ], to study that resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells [ncbi , more ], to study the effect of ERK and p38 on 4E-BP1 expression [ncbi , more ], to study ras activation by acute hyperglycemia [ncbi , more ], to study the expression of hypertonicity-induced aquaporin-1 (AQP1) which is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene [ncbi , more ], to identify a putative G protein-coupled receptors (GPCR) as an intermediary in meiotic maturation of fish oocytes [ncbi , more ], to demonstrate that Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway [ncbi , more ], to study the role of EWS/FLI-1 in the alteration of mesodermal cell differentiation [ncbi , more ], to study the role for PI 3-kinase in HHV-8 entry into the target cells and the role for PKC-zeta, MEK, and ERK at a post-viral entry stage of infection [ncbi , more ], to study the regulation of activity of the human tissue factor pathway inhibitor-2 promoter by the ERK/MAPK pathway [ncbi , more ], to study the interaction between TAB1 isoform and p38alpha [ncbi , more ]and to detect the protein levels of phosphorylated Erk-2, and in flow cytometry to analyze for phospho-p44/42 MAP kinase (Thr204/Tyr204) in human Jurkat E6-1 T cells [ncbi , more ]. Cell Signaling Technology ERK2 antibody was applied in 2002 to study the role for Leptin in normal mammary gland development and in normal and malignant breast cells from human [ncbi , more ], to study the function of beta-arrestin2 as a mediator of stromal cell-derived factor 1alpha-induced chemotaxis via the ASK1/p38 MAPK pathway [ncbi , more ], to investigate the phosphorylation of ERK1/2 in human microvascular endothelial cells isolated by enzymatic digestion of blood vessels taken from the mesentery of the small bowel (designated MM1 cells) [ncbi , more ], to study the regulation and the functional consequences after the extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease [ncbi , more ], to study the role of p42/44 MAPK and protein kinase B in CTGF induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells [ncbi , more ], to study the significance of the dimerization function associated with the BTB/POZ domain of Keap1 for sequestration of Nrf2 in the cytoplasm [ncbi , more ], to study the coupling of human 5-HT1A, 5-HT1B, and 5-HT1D receptors to the MAP kinase ERK [ncbi , more ], to study the regulation of heterodimerization beta1/beta2-adrenergic receptor for beta2-adrenergic receptor internalization and ERK signaling efficacy [ncbi , more ], to examine the levels of activated ERK in A2780 and OVCAR5 ovarian cancer cell lines and human HEK293 cells [ncbi , more ], to study the regulation of the phosphorylation of MAP kinases by UVB [ncbi , more ], to further elucidate the activation mechanism for intracellular signaling mediated by interaction between Dok1 and phosphorylated RET [ncbi , more ], to investigate ERK activity in A549 human lung cancer cells [ncbi , more ], to study the regulatory role of protein kinase A anchoring protein (AKAP) related protein in the modulation of SPHK1 activity in human HEK 293 cells [ncbi , more ], to study stress-induced ATF6 phosphorylation [ncbi , more ], to study the ERK5 signaling pathway regulation by PTP-SL [ncbi , more ], to detect phosphorylated p42 MAPK in chlorate-treated Rama 27 fibroblasts [ncbi , more ], to study cell survival by GLP-2R signaling [ncbi , more ], to study a potential role for tyrosine phosphatases [ncbi , more ], to study the role for the interaction between RACK1 and insulin-like growth factor 1 (IGF-1) receptor in regulating IGF-1-mediated Akt activation and protection from cell death [ncbi , more ], to study the role of CD147 as a cell surface receptor for CyPA and an essential component in the CyPA-initiated signaling cascade that culminates in ERK activation [ncbi , more ], to detect Erk-2 in HUVEC [ncbi , more ], to study expression of p53, ErbB1, ErbB2, and Raf-1 in lung cancer [ncbi , more ], to detect phospho-ERK2 in D5 and vector HEK293 cells untreated or treated with insulin [ncbi , more ], to study the role of Ng in neural function using a strain of Ng knockout mouse [ncbi , more ], to study the role of RSK in signaling chemokine responses and synthesis in astrocytes [ncbi , more ], to detect phospho-ERK2 in A549 cells [ncbi , more ], to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas [ncbi , more ], to investigate a novel mechanism for the regulation of Rac activity and lamellipodia formation by RET tyrosine kinase [ncbi , more ], to study the role for Q227L-Galpha in inhibiting growth of established tumors of later-stage human breast cancer cells in athymic mice [ncbi , more ], to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells [ncbi , more ], to study the role of KSR in the Raf/MEK/ERK kinase cascade [ncbi , more ]and to study IL-1 mediated MUC2 gene expression and mucin secretion in NCI-H292 cells via zctivation of PKC-MEK/ERK, and PI3K in human airway epithelial cells [ncbi , more ]. Cell Signaling Technology ERK2 antibody was employed in 2001 to study migration and signal transduction in corneal epithelial cells [ncbi , more ], to study the role of IG20 in TNF--induced apoptosis and activation of caspase-8 and 3 [ncbi , more ], to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ], to study the role of PDEgamma in regulating p42/p44 mitogen-activated protein kinase signaling in human embryonic kidney 293 cells [ncbi , more ], to study the novel mitogen-activated protein kinase phosphatase, MKP-7 [ncbi , more ], to study the regulation of Ca2+/Calmodulin-dependent eNOS activity by the phosphorylation of eNOS Thr495 [ncbi , more ], to identify a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-Cell receptor-mediated activation of PLC-1 and NFAT [ncbi , more ], to study the role of docking protein FRS2 in mitogen-activated protein kinase signaling cascade [ncbi , more ], to study the role of filamin-A in participating in CaR-mediated activation of mitogen-activated protein kinaseas by binding to the CaR's carboxyl-terminal tail [ncbi , more ], to investigate the inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade [ncbi , more ], to study the transcriptional program induced by Raf in epithelial cells [ncbi , more ], to study growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors [ncbi , more ], to study the effects of flavopiridol on PMA-induced differentiation and CDKI expression in human myeloid leukemia cells [ncbi , more ], to study the effect of SNT1 on ERK activation and neuronal differentiation in PC12 cells [ncbi , more ], to study the role of 7 nicotinic receptor in transduing signals to phosphatidylinositol 3-kinase to block a-amyloid-induced neurotoxicity [ncbi , more ], to Smad, ERK1/2, and p38 mitogen-activated protein kinase pathway cross-talka in chondrogenic ATDC5 cells [ncbi , more ], to study the mechanisms of Raf-1 activation [ncbi , more ], to study ERK2 nuclear shuttling in RBL-2H3 cells [ncbi , more ], to study Rho-ERK6 gene expression regulation pathway [ncbi , more ], to study the interactions between a purine analogue and kinase inhibitor UCN-01 in human leukemia and lymphoma cells [ncbi , more ], to study the role of CD45 in monocytic cells [ncbi , more ], to study a novel mechanism of cooperation between c-Kit and erythropoietin receptor [ncbi , more ]and to detect phospho-ERK2 in NIH-3T3 fibroblasts transfected with expression vector for GFP and C-terminal-truncated STAT3 [ncbi , more ].

Feedback from the author

Clone/Cat no (supplier): clone 16 (BD transduction); Host: mouse; western blot: we are happy with it; immunoprecipitation: not done; IF: we are happy with it; IHC: not done [ncbi , more ]. Martin K Angele et al. utilized BD Biosciences ERK2 antibody to determine whether differences in the activation of p38 by phosphorylation (p38-P) might contribute to the sex-dimorphic immune response following T-H [ncbi , more ] in 2003 and Toru Furukawa et al. used BD Biosciences ERK2 antibody to identify DUSP6 as one of the key players in the tumor suppressive pathway and as a promising molecular target for curing patients with pancreatic cancer [ncbi , more ]. Christine Guntermann et al. employed BD Biosciences ERK2 antibody to study a potential role for tyrosine phosphatases [ncbi , more ] in 2002 and Veronique Bereziat et al. used BD Biosciences ERK2 antibody to study insulin receptor catalytic activity inhibition [ncbi , more ]. BD Biosciences ERK2 antibody was employed in 2001 to study the role of PDEgamma in regulating p42/p44 mitogen-activated protein kinase signaling in human embryonic kidney 293 cells [ncbi , more ], to study the transcriptional program induced by Raf in epithelial cells [ncbi , more ]and to study the downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase [ncbi , more ].